VagiVital
Manufacturing · China · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Hong Kong, ChinaPhone Number
+46 103444988Website
www.vagivital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About VagiVital
VagiVital® is a patent pending hormone free self-care product for the treatment of vaginal atrophy and vaginal dryness. The product has been tested in randomised clinical studies (vaginal atrophy) with very positive results both for objective (vaginal pH and proportion of superficial cells in the vaginal mucosa) and subjective (most bothersome symptoms, such as vaginal dryness, vaginal irritation/itching, dyspareunia and dysuria) parameters. The magnitude of symptom relief is on par with that demonstrated with e.g. prescription estrogen based products on the market today. It was very well tolerated and caused no serious adverse effects. VagiVital®was launched in Sweden as a non-prescription self-care product in July 2018 (see www.vagivital.com).Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VagiVital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if VagiVital had a recent Job posting/layoffs
Product Launch: Get notified when VagiVital launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on VagiVital recently announced quarterly report
VagiVital, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once VagiVital has new funding data
Check if VagiVital has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at VagiVital
Check out if VagiVital is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
VagiVital is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VagiVital is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VagiVital.
VagiVital Tech Stack
A closer look at the technologies used by VagiVital
VagiVital News & Media
Lune North America, Inc. Introduces New Products for the VagiVital® Range of Hormone-Free Products for The Treatment of Vaginal Dryness
VagiVital Product Range Now Available on Amazon and www.us.vagivital.com **Interviews Available with Carolyn DeLucia, M.D., FACOG** NASHVILLE, Tenn., March 21, 2022 /PRNewswire/ -- Since 2018, VagiVital® has been a global leader in non-prescription self-care products for women. Lune North...INTERIM REPORT Period from January 2021 to September 2021
Lune Group OY incl subsidiary is consolidated in the group from 2020-06-03 Peptonic Medical AB (publ) org nr 556776-3064 (www.spotlightstockmarket.com ticker: PMED) Group, Lune Group OY incl subsidiary is included from 2020-06-03 2021 THIRD QUARTER (Jul-Sep) · Net sales of products KSEK 7,234 (9,260) · Gross profit KSEK 4,493 (6,228), Gross margin 62% (67%) · Operating loss KSEK -9,853 (-7,264) · Loss per share SEK -0.05 (-0.04) 2021 FIRST NINE MONTHS (Jan-Sep) · Net salesClinical study with VagiVital® in women undergoing cancer treatment and suffering from vaginal atrophy now published
Peptonic Medical (publ) (‘Peptonic’ or ‘the Company’) informs that the latest clinical study with VagiVital® has been published. The objective of the study was to investigate whether, and to what extent, VagiVital® can relieve symptoms associated with vaginal atrophy in women taking aromatase inhibitors (antiestrogens) as part of their cancer treatment. The study shows that VagiVital® offers strong relief of the most bothersome symptoms such as vaginal dryness, vaginal itching and pain during sePeptonics enters into VagiVital® distributor agreement with Revisage in Poland
Peptonic Medical (publ) (“Peptonic” or “Bolaget”) today announced it has signed a distributor agreement with Revisage concerning sales and distribution of VagiVital® AktivGel in Poland. Revisage is granted the exclusive rights to market and sell VagiVital® AktivGel to medical and aesthetic clinics in Poland. – We are very pleased to have entered into this agreement with Revisage. It gives us an excellent opportunity to assess the reception of VagiVital® in a channel where treatments of vaginal m
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VagiVital
Sign Up For FreeTo access detailed company insights
VagiVital® is a patent pending hormone free self-care product for the treatment of vaginal atrophy and vaginal dryness. The product has been tested in randomised clinical studies (vaginal atrophy) with very positive results both for objective (vaginal pH and proportion of superficial cells in the vaginal mucosa) and subjective (most bothersome symp... Read More
